Kumar Dinesh, Nepali Kunal, Bedi P M S, Kumar Suresh, Malik Fayaz, Jain Subheet
Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab-143005.
Anticancer Agents Med Chem. 2015;15(6):793-803. doi: 10.2174/1871520615666150318101436.
4,6-diarylpyrimidones as constrained chalcone analogues have been synthesised in the present study. The synthesised compounds were evaluated against a panel of human cancer cell lines. Striking selectivity was displayed by the compounds against MiaPaCa (Pancreatic) cell lines while PC-3 (prostate) and A-549 (lung) cell lines were almost resistant to the exposure of the test compounds. Compound SK - 25 exhibited remarkable cytotoxicity against MiaPaca-2 cell line with an IC50 value of 1.95 µM and was found to induce apoptosis evidenced through phase contrast microscopy, DAPI staining and mitochondrial membrane potential loss. The cell phase distribution studies indicated that the apoptotic population increased from 1.79% in control sample to 30.33 % in sample treated with 20 µM compound SK-25.
在本研究中合成了作为受限查尔酮类似物的4,6 - 二芳基嘧啶酮。对合成的化合物针对一组人类癌细胞系进行了评估。这些化合物对MiaPaCa(胰腺)细胞系表现出显著的选择性,而PC - 3(前列腺)和A - 549(肺)细胞系对测试化合物的暴露几乎具有抗性。化合物SK - 25对MiaPaca - 2细胞系表现出显著的细胞毒性,IC50值为1.95 µM,并且通过相差显微镜、DAPI染色和线粒体膜电位丧失证明其可诱导细胞凋亡。细胞周期分布研究表明,凋亡群体从对照样品中的1.79%增加到用20 µM化合物SK - 25处理的样品中的30.33%。